Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1135
| Despition | ACTH Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1329 | PDE6 Beta Blocking Peptide (AC1329) | 250 µg | inquiry |
| ACPP-1495 | Cofilin Blocking Peptide (AC1495) | 250 µg | inquiry |
| ACPP-1464 | Human ERLIN2 Protein (AC1464) | 5 µg | inquiry |
| ACPP-1168 | KCNJ5 Blocking Peptide (AC1168) | 250 µg | inquiry |
| ACPP-1455 | Human PIN1 Protein (AC1455) | 5 µg | inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
| ACPP-1612 | Human Vimentin Protein, GST (AC1612) | 2 µg | inquiry |
| ACPP-1808 | Human LIF Protein, Yeast (AC1808) | 5 µg | inquiry |
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1136 | TYRO3 Blocking Peptide (AC1136) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.